• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sempra Appoints Jennifer M. Kirk to Board of Directors

    6/20/24 4:15:00 PM ET
    $MDT
    $SRE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Natural Gas Distribution
    Utilities
    Get the next $MDT alert in real time by email

    SAN DIEGO, June 20, 2024 /PRNewswire/ -- Sempra (NYSE:SRE) (BMV:SRE) today announced the appointment of Jennifer M. Kirk to the company's board of directors effective June 20, 2024. Kirk is currently the global controller and chief accounting officer of Medtronic plc (NYSE:MDT) and has deep executive experience in finance, accounting and capital market activities, including more than 20 years in the energy industry.

    Jennifer M. Kirk

    "Bringing new perspectives into the boardroom is a critical component of our effort to support the company's mission to build North America's premier energy infrastructure company," said Jeffrey W. Martin, Sempra chairman and CEO. "Our board of directors embody a diverse set of skills, experiences and viewpoints that help guide Sempra's corporate strategy and overall business success. Jennifer's strong accounting and finance experience, coupled with her understanding of the energy business, will be a great complement to the board as we advance our corporate strategy and oversee financial discipline, risk management and ethical practices."

    Before joining Medtronic, Kirk, 49, worked at Occidental Petroleum Corporation for more than two decades, serving in roles of increasing responsibility, including senior vice president of integration and value capture, and vice president, controller and principal accounting officer.

    Kirk serves on the board of directors of Republic Services, where she is chair of the audit committee. She holds a bachelor's degree in economics from UC Santa Barbara and a master's degree in business administration from California State University, Bakersfield.

    With the appointment of Kirk, Sempra will have 10 directors with three having been newly elected over the past five years, reflecting the company's commitment to periodic board refreshment to ensure fresh and diverse perspectives are present in the boardroom. Kirk will serve on the board's audit committee and the safety, sustainability and technology committee.

    About Sempra

    Sempra (NYSE:SRE) is a leading North American energy infrastructure company focused on delivering energy to nearly 40 million consumers. As owner of one of the largest energy networks on the continent, Sempra is electrifying and improving the energy resilience of some of the world's most significant economic markets, including California, Texas, Mexico and global energy markets. The company is recognized as a leader in sustainable business practices and for its high-performance culture focused on safety and operational excellence, as demonstrated by Sempra's inclusion in the Dow Jones Sustainability Index North America and in The Wall Street Journal's Best Managed Companies. More information about Sempra is available at sempra.com and on social media @Sempra.

     

    Sempra Logo (PRNewsfoto/Sempra)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/sempra-appoints-jennifer-m-kirk-to-board-of-directors-302177421.html

    SOURCE Sempra

    Get the next $MDT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MDT
    $SRE

    CompanyDatePrice TargetRatingAnalyst
    Medtronic plc.
    $MDT
    6/4/2026$90.00Neutral → Buy
    BTIG Research
    Medtronic plc.
    $MDT
    5/21/2026$84.00Neutral
    Goldman
    DBA Sempra
    $SRE
    4/21/2026$108.00Buy
    Truist
    DBA Sempra
    $SRE
    3/4/2026Hold → Buy
    Argus
    Medtronic plc.
    $MDT
    2/13/2026$116.00Overweight
    Barclays
    Medtronic plc.
    $MDT
    2/9/2026$121.00Hold → Buy
    Needham
    Medtronic plc.
    $MDT
    2/3/2026$117.00Buy
    Citigroup
    Medtronic plc.
    $MDT
    1/30/2026$114.00Overweight
    Wells Fargo
    More analyst ratings

    $MDT
    $SRE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ECA LNG Phase 1 Achieves First LNG Production

    HOUSTON, June 4, 2026 /PRNewswire/ -- Sempra Infrastructure, a subsidiary of Sempra (NYSE:SRE), today announced that the ECA LNG Phase 1 liquefaction project in Ensenada, Mexico, has successfully started producing liquefied natural gas (LNG) as part of the commissioning process toward commercial operations."This achievement reflects the dedication of the entire ECA LNG Phase 1 team and their unwavering commitment to the highest standards of successful project development," said Justin Bird, CEO of Sempra Infrastructure. "The production of first LNG marks a significant milestone on the path to full operations expected in the coming months, enabling the delivery of reliable and secure energy f

    6/4/26 7:00:00 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    Medtronic submits 510(k) filings to expand Hugo™ robotic-assisted surgery system into general and gynecologic specialties in the United States

    Company also announces 510(k) pending for LigaSure™ RAS Maryland instrument on the Hugo RAS system, and 510(k) clearance for ProGrip™ Advanced self-gripping polypropylene mesh for use in robotic-assisted ventral hernia repair surgeriesGALWAY, Ireland, June 3, 2026 /PRNewswire/ -- Medtronic (NYSE:MDT), a global leader in healthcare technology, today announced significant milestones to unlock expanded indications for the Hugo™ robotic-assisted surgery (RAS) system in the United States and to shape the future of surgery.General surgery indication including hernia repair — 510(k) clearance submittedEmbrace Gynecology Investigational Device Exemption (IDE) clinical study — completed enrollmentGyn

    6/3/26 7:05:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Medtronic announces strategic investments to support future expansion of cardiac ablation portfolio as physician demand for Affera™ technologies broadens

    Investments in intracardiac echocardiography (ICE) technologies highlight Medtronic's commitment to driving durable growth in the cardiac ablation business through a differentiated portfolio of technologiesGALWAY, Ireland, June 3, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced strategic investments in two privately held companies focused on the development of intracardiac echocardiography (ICE) catheter technologies. ICE catheters provide real-time, high-resolution imaging of the heart during electrophysiology (EP) procedures for cardiac arrhythmias such as atrial fibrillation (Afib). Medtronic intends to integrate ICE into the Affera

    6/3/26 6:55:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $MDT
    $SRE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kirk Jennifer M bought $93,440 worth of shares (1,000 units at $93.44) (SEC Form 4)

    4 - SEMPRA (0001032208) (Issuer)

    3/13/26 5:07:15 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    Director Mark Richard J bought $251,164 worth of shares (2,692 units at $93.30), increasing direct ownership by 18% to 17,376 units (SEC Form 4)

    4 - SEMPRA (0001032208) (Issuer)

    3/11/26 7:19:04 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    Director Warner Cynthia J bought $232,375 worth of shares (2,500 units at $92.95), increasing direct ownership by 28% to 11,275 units (SEC Form 4)

    4 - SEMPRA (0001032208) (Issuer)

    3/11/26 7:18:39 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    $MDT
    $SRE
    SEC Filings

    View All

    SEC Form FWP filed by DBA Sempra

    FWP - SEMPRA (0001032208) (Subject)

    6/4/26 4:15:03 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    SEC Form 424B5 filed by DBA Sempra

    424B5 - SEMPRA (0001032208) (Filer)

    6/4/26 9:26:48 AM ET
    $SRE
    Natural Gas Distribution
    Utilities

    Medtronic plc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Medtronic plc (0001613103) (Filer)

    6/3/26 6:47:08 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $MDT
    $SRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief HR Officer Walter Matthew R. converted options into 9,149 units of Ordinary Shares, increasing direct ownership by 28% to 41,529 units (SEC Form 4)

    4 - Medtronic plc (0001613103) (Issuer)

    5/28/26 4:26:58 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    EVP & Pres Neuroscience Wall Brett A. converted options into 26,907 units of Ordinary Shares, increasing direct ownership by 49% to 82,183 units (SEC Form 4)

    4 - Medtronic plc (0001613103) (Issuer)

    5/28/26 4:26:23 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chairman and CEO Martha Geoffrey converted options into 94,963 units of Ordinary Shares, increasing direct ownership by 38% to 343,099 units (SEC Form 4)

    4 - Medtronic plc (0001613103) (Issuer)

    5/28/26 4:25:58 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $MDT
    $SRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Medtronic upgraded by BTIG Research with a new price target

    BTIG Research upgraded Medtronic from Neutral to Buy and set a new price target of $90.00

    6/4/26 8:39:35 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Goldman resumed coverage on Medtronic with a new price target

    Goldman resumed coverage of Medtronic with a rating of Neutral and set a new price target of $84.00

    5/21/26 8:09:17 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Truist initiated coverage on Sempra Energy with a new price target

    Truist initiated coverage of Sempra Energy with a rating of Buy and set a new price target of $108.00

    4/21/26 7:34:59 AM ET
    $SRE
    Natural Gas Distribution
    Utilities

    $MDT
    $SRE
    Financials

    Live finance-specific insights

    View All

    Sempra Declares Common Dividend

    SAN DIEGO, May 13, 2026 /PRNewswire/ -- Sempra (NYSE:SRE) today announced that its board of directors has declared a $0.6575 per share quarterly dividend on the company's common stock, which is payable July 15, 2026, to common stock shareholders of record at the close of business on June 25, 2026.About SempraSempra's mission is to build America's leading utility growth business. As owner of one of the largest energy networks on the continent, Sempra is electrifying and improving energy resilience in California and Texas, the two largest economies in the U.S. The company is recognized as a leader in responsible business practices and for its high-performance culture focused on safety and oper

    5/13/26 12:57:00 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    SoCalGas Urges Shareholders to Vote FOR Retirement of All Outstanding Shares of Preferred Stock at a Premium

    A $31.00 per share cash payment represents a premium of more than 20% over the recent market prices, estimated fair value, and par value of the shares LOS ANGELES, May 12, 2026 /PRNewswire/ -- Southern California Gas Company (SoCalGas) (OTCQB:SOCGP) (OTC:SOCGM), a subsidiary of Sempra (NYSE:SRE), today announced it will hold a Special Meeting of Shareholders (the "Special Meeting") on July 13, 2026. The anticipated record date for the Special Meeting is May 18, 2026, and only shareholders at the close of business on that date will be eligible to vote.At the Special Meeting, SoCalGas will seek approval from holders of its 6% Preferred Stock, par value $25.00, and 6% Preferred Stock, Series A,

    5/12/26 4:15:00 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    ONCOR REPORTS FIRST QUARTER 2026 RESULTS

    DALLAS, May 7, 2026 /PRNewswire/ -- Oncor Electric Delivery Company LLC ("Oncor") today reported net income of $212 million for the three months ended March 31, 2026, compared to net income of $181 million in the three months ended March 31, 2025. The increase in net income of $31 million was driven by overall higher revenues primarily attributable to an increase in revenues recognized related to the Unified Tracker Mechanism ("UTM") and the System Resiliency Plan ("SRP"), updated interim rates to reflect increases in invested capital, and customer growth, partially offset by lower customer consumption, primarily attributable to milder weather, higher interest expense and depreciation expens

    5/7/26 8:00:00 AM ET
    $SRE
    Natural Gas Distribution
    Utilities

    $MDT
    $SRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by DBA Sempra

    SC 13G - SEMPRA (0001032208) (Subject)

    11/8/24 10:52:39 AM ET
    $SRE
    Natural Gas Distribution
    Utilities

    SEC Form SC 13G/A filed by Medtronic plc. (Amendment)

    SC 13G/A - Medtronic plc (0001613103) (Subject)

    2/13/24 5:09:43 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G/A filed by DBA Sempra (Amendment)

    SC 13G/A - SEMPRA (0001032208) (Subject)

    2/13/24 4:56:00 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    $MDT
    $SRE
    Leadership Updates

    Live Leadership Updates

    View All

    Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company

    GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to become fully independent.  Chad brings over 25 years of financial leadership experience across healthcare, consumer, and industrial sectors. Most recently, he served as CFO at BIC (BB:PA), a pu

    7/8/25 8:45:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Medtronic Board appoints Dr. Joon Lee as a new director

    GALWAY, Ireland, June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board. "We are thrilled to welcome Dr. Lee, a highly respected interventional cardiologist and healthcare executive, to Medtronic's Board of Directors," said Geoff Martha, chairman and chief executive officer. "Dr. Lee brings deep expertise as a clinical researcher, academic leader, and physician executive with dec

    6/23/25 4:15:00 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Kayne Anderson Energy Infrastructure Fund Announces Appointment of New Independent Directors

    HOUSTON, May 27, 2025 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the "Company" or "KYN") announced today the appointments of Holli C. Ladhani and Michael N. Mears as independent directors of the Company, effective immediately. Following the retirements of Anne K. Costin and Albert L. Richey earlier this year, the appointments of Ms. Ladhani and Mr. Mears return the Company's Board to eight members, seven of whom are independent. Holli C. Ladhani is an experienced executive and board director in the energy, chemicals, power, and infrastructure sectors. Ms. Ladhani most recently served as President, Chief Executive Officer, and a member of the board of directors of

    5/27/25 4:15:00 PM ET
    $DVN
    $KYN
    $PWR
    Oil & Gas Production
    Energy
    Finance/Investors Services
    Finance